ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Modifies Pap Test Guidelines

November 27, 1987

Drug Discovery Group Announcement Issued

January 7, 1983

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982

Breast Cancer Risk Increases With Repeated CT Imaging

December 28, 2012

Panel Tells Carter Cancer Program Needs More Money

March 4, 1977